Kate Fife - Concepedia

Author

Kate Fife

Addenbrooke's Hospital ORCID

Also Known As

Fife, Kate, K Fife, K. Fife, K. M. Fife, K.M. FIFE, K.M. Fife, Kate Fife, Kate M. Fife, Paul Fields

127

Publications

5.4K

Citations

H-Index

Concepts

All Affiliations

Addenbrooke's Hospital Cambridge University Hospitals NHS Foundation Trust University of Cambridge Royal Marsden Hospital University of Glasgow

About

Kate Fife is an author at Addenbrooke's Hospital specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	995
2	Health Sciences	4	4	84
3	Arts	1	1	12
4	Humanities	1	1	12
5	Cell Biology	1	1	35

Kate Fife

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma Robert J. Motzer, Thomas E. Hutson, David Cella, New England Journal of Medicine	2013	1.9K
Determinants of Outcome in Melanoma Patients With Cerebral Metastases Kate Fife, Marjorie H. Colman, Graham Stevens, Journal of Clinical Oncology	2004	441
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial Nicole Basset‐Séguin, Axel Hauschild, Rainer Kunstfeld, European Journal of Cancer	2017	281
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial Nicole Basset‐Séguin, Axel Hauschild, Jean‐Jacques Grob, The Lancet Oncology Open-label TrialMedicinePre-planned Interim AnalysisDermatologyCancer Treatment	2015	242
Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi‚s sarcoma Mark Bower, Paul Fox, Kate Fife, AIDS	1999	169
Modafinil for the Treatment of Fatigue in Lung Cancer: Results of a Placebo-Controlled, Double-Blind, Randomized Trial Anna Spathis, Kate Fife, Fiona Blackhall, Journal of Clinical Oncology	2014	124
British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020* Stephen Keohane, Jonathan Botting, P.G. Budny, British Journal of Dermatology	2020	113
Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR) Michael J. Seckl, Christian H. Ottensmeier, Michael Cullen, Journal of Clinical Oncology MedicineCancer ManagementPhase IiiPharmacologyClinical Trials	2017	111
Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial Tim Eisen, Heikki Joensuu, Paul Nathan, The Lancet Oncology UrologyOncologyGenitourinary CancerUnresectable Renal-cell CarcinomaClinical Trials	2012	108
Selection of Oncogenic Mutant Clones in Normal Human Skin Varies with Body Site Joanna C. Fowler, Charlotte King, Chris Bryant, Cancer Discovery	2020	98

Page 1